chr9-99105255-TGGCGGCGGCGGCGGC-T

Variant summary

Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BP6

The NM_004612.4(TGFBR1):​c.64_78delGCGGCGGCGGCGGCG​(p.Ala22_Ala26del) variant causes a conservative inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000023 in 1,043,388 control chromosomes in the GnomAD database, with no homozygous occurrence. It is difficult to determine the true allele frequency of this variant because it is of type DEL_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. There is a variant allele frequency bias in the population database for this variant (GnomAdExome4), which may indicate mosaicism or somatic mutations in the reference population data. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. A22A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000021 ( 0 hom., cov: 30)
Exomes 𝑓: 0.000023 ( 0 hom. )

Consequence

TGFBR1
NM_004612.4 conservative_inframe_deletion

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:3

Conservation

PhyloP100: 2.84

Publications

24 publications found
Variant links:
Genes affected
TGFBR1 (HGNC:11772): (transforming growth factor beta receptor 1) The protein encoded by this gene forms a heteromeric complex with type II TGF-beta receptors when bound to TGF-beta, transducing the TGF-beta signal from the cell surface to the cytoplasm. The encoded protein is a serine/threonine protein kinase. Mutations in this gene have been associated with Loeys-Dietz aortic aneurysm syndrome (LDAS). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2008]
TGFBR1 Gene-Disease associations (from GenCC):
  • familial thoracic aortic aneurysm and aortic dissection
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • Loeys-Dietz syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • Loeys-Dietz syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia, Genomics England PanelApp, G2P
  • multiple self-healing squamous epithelioma
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -1 ACMG points.

BP6
Variant 9-99105255-TGGCGGCGGCGGCGGC-T is Benign according to our data. Variant chr9-99105255-TGGCGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 496263. Variant chr9-99105255-TGGCGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 496263. Variant chr9-99105255-TGGCGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 496263. Variant chr9-99105255-TGGCGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 496263. Variant chr9-99105255-TGGCGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 496263. Variant chr9-99105255-TGGCGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 496263. Variant chr9-99105255-TGGCGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 496263. Variant chr9-99105255-TGGCGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 496263. Variant chr9-99105255-TGGCGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 496263. Variant chr9-99105255-TGGCGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 496263. Variant chr9-99105255-TGGCGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 496263. Variant chr9-99105255-TGGCGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 496263. Variant chr9-99105255-TGGCGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 496263. Variant chr9-99105255-TGGCGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 496263. Variant chr9-99105255-TGGCGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 496263. Variant chr9-99105255-TGGCGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 496263. Variant chr9-99105255-TGGCGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 496263. Variant chr9-99105255-TGGCGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 496263. Variant chr9-99105255-TGGCGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 496263. Variant chr9-99105255-TGGCGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 496263. Variant chr9-99105255-TGGCGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 496263. Variant chr9-99105255-TGGCGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 496263. Variant chr9-99105255-TGGCGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 496263. Variant chr9-99105255-TGGCGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 496263. Variant chr9-99105255-TGGCGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 496263. Variant chr9-99105255-TGGCGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 496263. Variant chr9-99105255-TGGCGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 496263. Variant chr9-99105255-TGGCGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 496263. Variant chr9-99105255-TGGCGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 496263. Variant chr9-99105255-TGGCGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 496263. Variant chr9-99105255-TGGCGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 496263. Variant chr9-99105255-TGGCGGCGGCGGCGGC-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 496263.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TGFBR1NM_004612.4 linkc.64_78delGCGGCGGCGGCGGCG p.Ala22_Ala26del conservative_inframe_deletion Exon 1 of 9 ENST00000374994.9 NP_004603.1 P36897-1Q5T7S2B4DXN7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TGFBR1ENST00000374994.9 linkc.64_78delGCGGCGGCGGCGGCG p.Ala22_Ala26del conservative_inframe_deletion Exon 1 of 9 1 NM_004612.4 ENSP00000364133.4 P36897-1

Frequencies

GnomAD3 genomes
AF:
0.0000211
AC:
3
AN:
142422
Hom.:
0
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000464
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.0000233
AC:
21
AN:
900966
Hom.:
0
AF XY:
0.0000331
AC XY:
14
AN XY:
422760
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
17388
American (AMR)
AF:
0.00
AC:
0
AN:
2804
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
7300
East Asian (EAS)
AF:
0.00
AC:
0
AN:
9216
South Asian (SAS)
AF:
0.000111
AC:
2
AN:
18064
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5144
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
1952
European-Non Finnish (NFE)
AF:
0.0000223
AC:
18
AN:
807766
Other (OTH)
AF:
0.0000319
AC:
1
AN:
31332
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000212), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.392
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000211
AC:
3
AN:
142422
Hom.:
0
Cov.:
30
AF XY:
0.00
AC XY:
0
AN XY:
69286
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
39216
American (AMR)
AF:
0.00
AC:
0
AN:
14538
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3342
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4840
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4610
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
8144
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
288
European-Non Finnish (NFE)
AF:
0.0000464
AC:
3
AN:
64630
Other (OTH)
AF:
0.00
AC:
0
AN:
1962
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.442
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
37

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:2
May 27, 2022
Clinical Genetics Laboratory, Skane University Hospital Lund
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 22, 2017
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: The TGFBR1 c.64_78delGCGGCGGCGGCGGCG (p.Ala22_Ala26del) variant involves the deletion of 15 nucleotides and results an inframe deletion of 5 out of 9 consecutive Alanines in N-terminus of TGFBR1 protein. These repeating Alanines are not located in any known domain (InterPro). One in silico tool predicts a benign outcome for this variant. There is no or extremely low coverage in this region in control databases (ExAC, gnomAD, ESP, or 1000Gs). c.70_78delGCGGCGGCG (rs11466445), a shorter deletion in this Alanine repeat region, is classified as benign/likely benign by 8 clinical diagnostics laboratories in ClinVar. However, the variant of interest has not, to our knowledge, been reported in affected individuals via publications and/or reputable databases/clinical diagnostic laboratories; nor evaluated for functional impact by in vivo/vitro studies. Because of the absence of clinical information and the lack of functional studies, the variant is classified as a variant of uncertain significance (VUS) until additional information becomes available. -

Jul 19, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Familial thoracic aortic aneurysm and aortic dissection Uncertain:1Benign:1
Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant, c.64_78del, results in the deletion of 5 amino acid(s) of the TGFBR1 protein (p.Ala22_Ala26del), but otherwise preserves the integrity of the reading frame. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate insufficient coverage at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with TGFBR1-related conditions. ClinVar contains an entry for this variant (Variation ID: 496263). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Jun 16, 2022
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
2.8
Mutation Taster
=157/43
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11466445; hg19: chr9-101867537; API